Mesa Laboratories Inc (MLAB)

Return on equity (ROE)

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net income	US$ in thousands	-254,246	930	1,871	3,274	1,349
Total stockholders’ equity	US$ in thousands	145,393	393,480	393,801	406,227	220,013
ROE		-174.87%	0.24%	0.48%	0.81%	0.61%

March 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $-254,246K ÷ $145,393K
= -174.87%

Mesa Laboratories Inc's return on equity (ROE) has shown significant fluctuations over the past five years. In the most recent period ending March 31, 2024, the company reported a negative ROE of -174.87%, indicating that the company had a net loss for the year in relation to its shareholder equity.

This negative ROE is a stark contrast to the previous years, with ROE ranging from 0.24% to 0.81% from 2021 to 2023. These figures suggest relatively low profitability levels compared to the industry average during those periods.

The sharp decline in ROE in 2024 could be attributed to various factors such as increased expenses, decline in revenues, or impairment charges impacting the company's earnings and shareholder equity. Investors and stakeholders may need to further investigate the underlying reasons for this significant negative ROE in order to assess the company's financial health and performance.